Drug Testing Market Growth & Trends
The global drug testing market size is expected to reach USD 8.45 billion by 2030, expanding at a CAGR of 4.8% from 2024 to 2030, according to a new report by Grand View Research, Inc. The introduction of innovative tests, stringent regulation mandating drug testing, and growing substance abuse & addiction are some of the factors anticipated to foster market growth during the forecast period.
Drug abuse and addiction is a global problem, affecting millions of people. As per the World Drug Report published by UNODC, in 2019, around 35.0 million people were suffering from drug use disorders globally. Such a high rate of drug abuse and substance use disorders has created a major demand for innovative tests to prevent, treat, and manage such cases. Several key players operating in this space are introducing innovative and efficient products to meet this growing demand.
For instance, in June 2019, Quidel Corporation received the U.S. FDA’s 510(k) clearance to market its fluorescence immunoassay—Quidel Triage TOX Drug Screen, 94600. This is intended for detecting the presence of metabolites or drugs in urine. Moreover, in June 2020, Cordant Health Solutions offered video-observed oral fluid drug testing to help courts & government agencies to monitor participants during the COVID-19 pandemic. This aided in combating several challenges faced by people with substance abuse disorders during the pandemic.
Continuous government initiatives and implementation of strict substance abuse testing regulations to ensure safety have derived the demand for its testing products. In July 2020, the New Zealand government introduced a new bill that provides police the power to conduct random roadside drug testing of drivers to reduce impaired driving in the country. The new bill allows usage of oral fluid tests to check drivers for substances such as cocaine, ecstasy, cannabis, opiates, methamphetamine, and benzodiazepines. Also, in February 2020, the Directorate General of Civil Aviation in India introduced extensive tests for pilots and flight crew members for psychoactive substances such as opioids & cannabis to ensure safe air travel.
Request a free sample copy or view report summary: https://www.grandviewresearch.com/industry-analysis/drug-testing-market
Drug Testing Market Report Highlights
- By product type, the consumables segment dominated the market in 2023, owing to its repetitive use to conduct substance abuse screening
- Based on sample type, the urine samples segment accounted for the largest revenue share in 2023, as it is the most common method of sample collection
- Increased unemployment and economic crisis due to the Covid-19 pandemic has made people more susceptible to substance abuse, thus created lucrative opportunities in the market
- The legalization of marijuana for medicinal as well as recreational use in several countries is anticipated to change the current scenario and may create demand for innovative testing solutions
- Stringent privacy rights in some countries are likely to limit substance abuse testing at workplaces, impeding market growth
- In Asia Pacific, the market is expected to witness lucrative growth over the forecast period as a result of the growing demand for substance abuse testing from emerging economies, such as China and India
Drug Testing Market Segmentation
Grand View Research has segmented the global drug testing market based on product, sample, drug, end-use, and region:
Drug Testing Product Outlook (Revenue, USD Million, 2018 – 2030)
- Consumables
- Instruments
- Rapid Testing Devices
- Services
Drug Testing Sample Outlook (Revenue, USD Million, 2018 – 2030)
- Urine Samples
- Oral Fluid Samples
- Hair Samples
- Other Samples
Drug Testing Drug Outlook (Revenue, USD Million, 2018 – 2030)
- Alcohol
- Cannabis/Marijuana
- Cocaine
- Opioids
- Amphetamine & Methamphetamine
- LSD
- Others
Drug Testing End-use Outlook (Revenue, USD Million, 2018 – 2030)
- Drug Testing Laboratories
- Workplaces
- Hospitals
- Others
Drug Testing Regional Outlook (Revenue in USD Million, 2018 – 2030)
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
Regional Insights
North America drug testing market dominated and accounted for a 39.5% share in 2023. This high share is attributable to the local presence of key global market players, such as Bio-Rad Laboratories, Laboratory Corporation of America Holdings, Thermo Fisher Scientific, F. Hoffmann-La Roche Ltd. and others. Moreover, the growth of the drug testing market in North America can majorly be attributed to the increasing incidence of abuse, stringent government regulations, and active screening programs. The governments are actively engaged in controlling the consumption of hazardous drugs to minimize the cost burden associated with it. In addition, the authorities are focusing on formulating new policies. For instance, in September 2023, San Francisco Human Services Agency (SFHSA) announced a new initiative that would need people suffering from substance use disorder who wish to gain access to county funds to enroll in treatment and services.
List of Key Players in Drug Testing Market
- Quest Diagnostics Incorporated
- Abbott
- F. Hoffmann-La Roche Ltd.
- Quidel Corporation
- Thermo Fisher Scientific, Inc.
- Siemens Healthcare GmbH
- Bio-Rad Laboratories, Inc.
- Agilent Technologies, Inc.
- Laboratory Corporation of America Holdings
- Clinical Reference Laboratory, Inc.
- Cordant Health Solutions
Browse Full Report: https://www.grandviewresearch.com/industry-analysis/drug-testing-market